Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Gefitinib is active in patients with brain metastasis from non-small cell lung cancer
Chunming Tsai
,
Chaohua Chiu
, Jialing Liou
, Peijiun Tsai
, Reuryperng Perng
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gefitinib is active in patients with brain metastasis from non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Gefitinib
100%
Brain Metastasis
100%
Disease
25%
Neoplasm
25%
Adverse Event
25%
Progression Free Survival
25%
Overall Survival
25%
Brain Disease
25%
Treatment of Non-Small Cell Lung Cancer
25%
Idiopathic Interstitial Pneumonia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Gefitinib
100%
Brain Metastasis
100%
Adverse Event
25%
Overall Survival
25%
Progression Free Survival
25%
Brain Disease
25%
Interstitial Pneumonia
25%
Disease
25%
Neoplasm
25%